Zobrazeno 1 - 10
of 2 979
pro vyhledávání: '"Merlin L"'
Autor:
Ivalda Macicame, Nilesh Bhatt, Edna Viegas, Adam Yates, Chiaka Nwoga, Raquel Matavele Chissumba, Vanessa Monteiro, Michelle Imbach, Mark Milazzo, Qun Li, Steven Schech, Tsedal Mebrahtu, Leigh Anne Eller, Edith Swann, Nelson L. Michael, Merlin L. Robb, Trevor A. Crowell, Christina S. Polyak, Ilesh Jani, on behalf of the RV363 Study Group
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Introduction Sub-Saharan Africa has a high burden of HIV, particularly among female sex workers (FSW) and men who have sex with men (MSM). Future clinical trials to evaluate vaccines and other interventions to prevent HIV will need to enroll
Externí odkaz:
https://doaj.org/article/1beb0da763a5476791b223fca0563eb8
Autor:
Bernard K. Turkson, Isaac K. Amponsah, Alfred Ofori Agyemang, Merlin L. K. Mensah, Reinhard I. Nketia, Desmond Nkrumah, Michael F. Baidoo, Abraham Y. Mensah, Emmanuel Achaab, Burnett Tetteh Accam
Publikováno v:
Clinical Phytoscience, Vol 10, Iss 1, Pp 1-12 (2024)
Abstract The use of herbal products for the treatment of malaria, has increased globally. However, inadequate scientific studies about the safety and effectiveness of such herbal products have been raised. Also, the reduced sensitivity of the malaria
Externí odkaz:
https://doaj.org/article/f0c44a8a1ae44f3a9811bbdbc733795d
Autor:
Manukumar Honnayakanahalli Marichannegowda, Saini Setua, Meera Bose, Eric Sanders-Buell, David King, Michelle Zemil, Lindsay Wieczorek, Felisa Diaz-Mendez, Nicolas Chomont, Rasmi Thomas, Leilani Francisco, Leigh Anne Eller, Victoria R. Polonis, Sodsai Tovanabutra, Alonso Heredia, Yutaka Tagaya, Nelson L. Michael, Merlin L. Robb, Hongshuo Song
Publikováno v:
EBioMedicine, Vol 109, Iss , Pp 105410- (2024)
Summary: Background: Nearly all transmitted/founder (T/F) HIV-1 are CCR5 (R5)-tropic. While previous evidence suggested that CXCR4 (X4)-tropic HIV-1 are transmissible, virus detection and characterization were not at the earliest stages of acute infe
Externí odkaz:
https://doaj.org/article/cb0d23262dfb444090a7d9f07063396f
Autor:
Boris Julg, Kathryn E. Stephenson, Frank Tomaka, Stephen R. Walsh, C. Sabrina Tan, Ludo Lavreys, Michal Sarnecki, Jessica L. Ansel, Diane G. Kanjilal, Kate Jaegle, Tessa Speidel, Joseph P. Nkolola, Erica N. Borducchi, Esmee Braams, Laura Pattacini, Eleanor Burgess, Shlomi Ilan, Yannic Bartsch, Katherine E. Yanosick, Michael S. Seaman, Daniel J. Stieh, Janine van Duijn, Wouter Willems, Merlin L. Robb, Nelson L. Michael, Bruce D. Walker, Maria Grazia Pau, Hanneke Schuitemaker, Dan H. Barouch
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-10 (2024)
Abstract Mosaic HIV-1 vaccines have been shown to elicit robust humoral and cellular immune responses in people living with HIV-1 (PLWH), that had started antiretroviral therapy (ART) during acute infection. We evaluated the safety and immunogenicity
Externí odkaz:
https://doaj.org/article/59601776515445b699048f239a5f3f75
Autor:
Myra Happe, Amelia R. Hofstetter, Jing Wang, Galina V. Yamshchikov, LaSonji A. Holman, Laura Novik, Larisa Strom, Francis Kiweewa, Salim Wakabi, Monica Millard, Colleen F. Kelley, Sarah Kabbani, Srilatha Edupuganti, Allison Beck, Florence Kaltovich, Tamar Murray, Susanna Tsukerman, Derick Carr, Carl Ashman, Daphne A. Stanley, Aurélie Ploquin, Robert T. Bailer, Richard Schwartz, Fatim Cham, Allan Tindikahwa, Zonghui Hu, Ingelise J. Gordon, Nadine Rouphael, Katherine V. Houser, Emily E. Coates, Barney S. Graham, Richard A. Koup, John R. Mascola, Nancy J. Sullivan, Merlin L. Robb, Julie A. Ake, Kirsten E. Lyke, Mark J. Mulligan, Julie E. Ledgerwood, Hannah Kibuuka, the VRC 208 and RV 422 study team
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-11 (2024)
Abstract Ebola virus disease (EVD) is a filoviral infection caused by virus species of the Ebolavirus genus including Zaire ebolavirus (EBOV) and Sudan ebolavirus (SUDV). We investigated the safety and immunogenicity of a heterologous prime-boost reg
Externí odkaz:
https://doaj.org/article/a738fdd17f884be498b68c55cc2e29cd
Autor:
Thembi Mdluli, Bonnie M. Slike, Daniel J. Curtis, Zhanna Shubin, Ursula Tran, Yifan Li, Vincent Dussupt, Letzibeth Mendez-Rivera, Suteeraporn Pinyakorn, Daniel J. Stieh, Frank L. Tomaka, Hanneke Schuitemaker, Maria G. Pau, Donn J. Colby, Eugène Kroon, Carlo Sacdalan, Mark de Souza, Nittaya Phanupak, Denise C. Hsu, Jintanat Ananworanich, Julie A. Ake, Lydie Trautmann, Sandhya Vasan, Merlin L. Robb, Shelly J. Krebs, Dominic Paquin-Proulx, Morgane Rolland
Publikováno v:
Cell Reports, Vol 43, Iss 6, Pp 114344- (2024)
Summary: A heterologous Ad26/MVA vaccine was given prior to an analytic treatment interruption (ATI) in people living with HIV-1 (mainly CRF01_AE) who initiated antiretroviral treatment (ART) during acute HIV-1. We investigate the impact of Ad26/MVA
Externí odkaz:
https://doaj.org/article/2a53194be3584d4cb1d89d2981acfbb5
Autor:
Ben Ainsworth, Jeremy Horwood, Scott R. Walter, Sascha Miller, Melanie Chalder, Frank De Vocht, James Denison-Day, Martha M. C. Elwenspoek, Helen J. Curtis, Chris Bates, Amir Mehrkar, Seb Bacon, Ben Goldacre, The OpenSAFELY Collaborative, Pippa Craggs, Richard Amlôt, Nick Francis, Paul Little, John Macleod, Michael Moore, Kate Morton, Cathy Rice, Jonathan Sterne, Beth Stuart, Lauren Towler, Merlin L. Willcox, Lucy Yardley
Publikováno v:
Implementation Science, Vol 18, Iss 1, Pp 1-13 (2023)
Abstract Background Germ Defence ( www.germdefence.org ) is an evidence-based interactive website that promotes behaviour change for infection control within households. To maximise the potential of Germ Defence to effectively reduce the spread of CO
Externí odkaz:
https://doaj.org/article/b4cdb07d7a8548fa9e7d0eb16f55da29
Autor:
Swati Jain, Gherman Uritskiy, Marthandan Mahalingam, Himanshu Batra, Subhash Chand, Hung V Trinh, Charles Beck, Woong-Hee Shin, Wadad Alsalmi, Gustavo Kijak, Leigh A Eller, Jerome Kim, Daisuke Kihara, Sodsai Tovanabutra, Guido Ferrari, Merlin L Robb, Mangala Rao, Venigalla B Rao
Publikováno v:
eLife, Vol 13 (2024)
A productive HIV-1 infection in humans is often established by transmission and propagation of a single transmitted/founder (T/F) virus, which then evolves into a complex mixture of variants during the lifetime of infection. An effective HIV-1 vaccin
Externí odkaz:
https://doaj.org/article/67dbb3b3745540c7a92cab8a513f8bfe
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2024)
Externí odkaz:
https://doaj.org/article/1e164788bece4c839e5113f519bfd086
Autor:
Valentine Sing’oei, Chiaka Nwoga, Adam Yates, John Owuoth, June Otieno, Erica Broach, Qun Li, Zebiba Hassen, Michelle Imbach, Mark Milazzo, Tsedal Mebrahtu, Merlin L. Robb, Julie A. Ake, Christina S. Polyak, Trevor A. Crowell
Publikováno v:
PLoS ONE, Vol 19, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/6b41a8fbcd8640a9bb50a53908dbc689